Pepgen inc. being investigated on behalf of pepgen inc. investors. contact levi & korsinsky for details

New york, ny / access newswire / march 13, 2025 / levi & korsinsky notifies investors that it has commenced an investigation of pepgen inc. ("pepgen inc.") (nasdaq:pepg) concerning possible violations of federal securities laws. pepgen issued a press release "announc[ing] its voluntary decision to temporarily pause the phase 2 connect2-edo51 study of pgn-edo51 in patients with duchenne muscular dystrophy (dmd) until the company can review results from the 10 mg/kg cohort in the ongoing phase 2 connect1-edo51 study.
PEPG Ratings Summary
PEPG Quant Ranking